Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, USA.
BMC Neurosci. 2013 Aug 9;14:86. doi: 10.1186/1471-2202-14-86.
Drp1 is the primary protein responsible for mitochondrial fission. Perturbations of mitochondrial morphology and increased fission are seen in neurodegeneration. While Drp1 degradation induced by Parkin overexpression can be prevented by proteasome inhibition, there are numerous links between proteasomal and autophagic processes in mitochondrial protein degradation. Here we investigated the role of autophagy in Drp1 regulation.
We demonstrate that autophagy plays a major role in the control of Drp1 levels. In HEK-293T cells, inhibitors of autophagy increase total Drp1 and levels of Drp1 in the mitochondrial cellular fraction. Similarly by silencing ATG7, which is required for initiation of autophagy, there is an increased level of Drp1. Because of the role of increased Drp1 in neurodegeneration, we then examined the ability to modulate Drp1 levels in neurons by inducing autophagy. We are able to decrease Drp1 levels in a time- and dose-dependent manner with the potent neuronal autophagy inducer 10-NCP, as well as structurally related compounds. Further, 10-NCP was able increase average mitochondrial size and length verifying a functional result of Drp1 depletion in these neurons.
These pharmacological and genetic approaches indicate that autophagy targets Drp1 for lysosomal degradation. Additionally these data suggest a mechanism, through Drp1 downregulation, which may partly explain the ability of autophagy to have a neuroprotective effect.
Drp1 是负责线粒体裂变的主要蛋白质。在神经退行性变中,可见到线粒体形态的改变和裂变的增加。虽然 Parkin 过表达诱导的 Drp1 降解可以被蛋白酶体抑制所阻止,但在线粒体蛋白降解中,蛋白酶体和自噬过程之间存在许多联系。在这里,我们研究了自噬在 Drp1 调节中的作用。
我们证明自噬在 Drp1 水平的控制中起着主要作用。在 HEK-293T 细胞中,自噬抑制剂增加总 Drp1 和线粒体细胞部分的 Drp1 水平。同样,通过沉默 ATG7(自噬起始所必需的),Drp1 的水平也会增加。由于 Drp1 水平增加在神经退行性变中的作用,我们随后研究了通过诱导自噬来调节神经元中 Drp1 水平的能力。我们能够以时间和剂量依赖的方式用强效神经元自噬诱导剂 10-NCP 以及结构相关的化合物降低 Drp1 水平。此外,10-NCP 能够增加平均线粒体大小和长度,证明了 Drp1 耗尽在这些神经元中的功能结果。
这些药理学和遗传学方法表明,自噬将 Drp1 作为溶酶体降解的靶标。此外,这些数据表明了一种机制,通过 Drp1 的下调,这可能部分解释了自噬具有神经保护作用的原因。